JP2023524444A5 - - Google Patents

Info

Publication number
JP2023524444A5
JP2023524444A5 JP2022565803A JP2022565803A JP2023524444A5 JP 2023524444 A5 JP2023524444 A5 JP 2023524444A5 JP 2022565803 A JP2022565803 A JP 2022565803A JP 2022565803 A JP2022565803 A JP 2022565803A JP 2023524444 A5 JP2023524444 A5 JP 2023524444A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
sequence shown
region containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524444A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029560 external-priority patent/WO2021222355A1/en
Publication of JP2023524444A publication Critical patent/JP2023524444A/ja
Publication of JP2023524444A5 publication Critical patent/JP2023524444A5/ja
Priority to JP2025284219A priority Critical patent/JP2026047374A/ja
Pending legal-status Critical Current

Links

JP2022565803A 2020-04-29 2021-04-28 医薬製剤 Pending JP2023524444A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025284219A JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017051P 2020-04-29 2020-04-29
US63/017,051 2020-04-29
PCT/US2021/029560 WO2021222355A1 (en) 2020-04-29 2021-04-28 Pharmaceutical formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025284219A Division JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Publications (2)

Publication Number Publication Date
JP2023524444A JP2023524444A (ja) 2023-06-12
JP2023524444A5 true JP2023524444A5 (cg-RX-API-DMAC10.html) 2024-03-28

Family

ID=76099009

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022565803A Pending JP2023524444A (ja) 2020-04-29 2021-04-28 医薬製剤
JP2025284219A Pending JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025284219A Pending JP2026047374A (ja) 2020-04-29 2025-12-26 医薬製剤

Country Status (9)

Country Link
US (1) US20230167175A1 (cg-RX-API-DMAC10.html)
EP (1) EP4142790A1 (cg-RX-API-DMAC10.html)
JP (2) JP2023524444A (cg-RX-API-DMAC10.html)
KR (1) KR20230004799A (cg-RX-API-DMAC10.html)
CN (1) CN115484980A (cg-RX-API-DMAC10.html)
AU (1) AU2021263813A1 (cg-RX-API-DMAC10.html)
CA (1) CA3173706A1 (cg-RX-API-DMAC10.html)
IL (1) IL297080A (cg-RX-API-DMAC10.html)
WO (1) WO2021222355A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20190408A (es) * 2017-02-02 2020-01-31 Amgen Inc Composición farmacéutica de bajo ph que comprende construcciones de anticuerpos que activan linfocitos t antecedentes

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
JPH02500329A (ja) 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
AU2001264946A1 (en) 2000-05-24 2001-12-03 Imclone Systems Incorporated Bispecific immunoglobulin-like antigen binding proteins and method of production
EP1786918A4 (en) 2004-07-17 2009-02-11 Imclone Systems Inc NEW BISPECIFIC ANTIBODY TETRAVALENT
CA2697922A1 (en) 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Compositions that bind multiple epitopes of igf-1r
EP2225275A4 (en) * 2007-11-28 2013-04-03 Medimmune Llc PROTEIN FORMULATION
PE20151179A1 (es) * 2012-11-01 2015-09-12 Abbvie Inc Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas
TWI793062B (zh) * 2015-07-31 2023-02-21 德商安美基研究（慕尼黑）公司 Ｄｌｌ３及ｃｄ３抗體構築體
DE102016124977B4 (de) 2016-12-20 2021-12-16 Endress+Hauser Flowtec Ag Verfahren zum Betreiben eines magnetisch-induktiven Durchflussmessgeräts und ein solches Durchflussmessgerät
CR20190408A (es) 2017-02-02 2020-01-31 Amgen Inc Composición farmacéutica de bajo ph que comprende construcciones de anticuerpos que activan linfocitos t antecedentes
MA48763A (fr) * 2017-05-05 2020-04-08 Amgen Inc Composition pharmaceutique comprenant des constructions d'anticorps bispécifiques pour un stockage et une administration améliorés
KR20200036889A (ko) * 2017-07-28 2020-04-07 에프. 호프만-라 로슈 아게 이중특이성 항체 제형
EP3688033A4 (en) * 2017-09-29 2021-06-23 Janssen Biotech, Inc. NEW FORMULATIONS THAT STABILIZE LOW DOSE ANTIBODY COMPOSITIONS

Similar Documents

Publication Publication Date Title
JP7590125B2 (ja) モノクローナル抗体製剤
US11286294B2 (en) Anti-RSV monoclonal antibody formulation
KR20090021298A (ko) 항-ｅｇｆｒ 항체의 동결건조 제제
US6616931B1 (en) Rotavirus vaccine formulations
US12186384B2 (en) Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
US6403098B1 (en) Rotavirus vaccine formulations
US20160375133A1 (en) Methods for producing high concentration lyophilized pharmaceutical formulations
US12251474B2 (en) Process for lyophilized pharmaceutical formulations of a therapeutic protein
WO2011012637A4 (en) Subcutaneous anti-her2 antibody formulation
CN101631563B (zh) 含有流感疫苗的冻干制剂及其制备方法
JP2019509311A5 (cg-RX-API-DMAC10.html)
AU739916B2 (en) Rotavirus vaccine formulations
JP2013531679A5 (cg-RX-API-DMAC10.html)
JP2023538669A5 (cg-RX-API-DMAC10.html)
US20230414760A1 (en) Pharmaceutical formulation
JP2022553058A5 (cg-RX-API-DMAC10.html)
JP2023524445A5 (cg-RX-API-DMAC10.html)
JP2026016480A5 (cg-RX-API-DMAC10.html)
JP2023541133A (ja) 凍結乾燥タンパク質製剤を作製する方法
JP7630625B2 (ja) 改善された凍結乾燥製剤
JP2023509354A5 (cg-RX-API-DMAC10.html)
JP2023501155A5 (cg-RX-API-DMAC10.html)
HK40093820A (en) Anti-rsv monoclonal antibody formulations
JP2022545553A5 (cg-RX-API-DMAC10.html)
JP2023524444A (ja) 医薬製剤